Collaboration agreement with QIAGEN


Our attorneys advised longtime client Novartis in a master collaboration agreement with QIAGEN N.V. to enable to development and commercialization of companion diagnostics to be paired with existing Novartis products as well as compounds in its development pipeline. QIAGEN, a Netherlands-based global provider of sample and assay technologies that are used to transform biological materials into valuable molecular information, markets more than 500 products around the world.

Email Disclaimer